Johns Hopkins University researchers have found that the Pre-mixed insulin analogues acts better than the conventional pre-mixed human insulin in the type 2 diabetes patients. The report funded by the Healthcare Research and Quality concludes that Pre-mixed insulin analogues helps to lower the sugar level down after meals.
The report represents a systematic review of 45 research studies and is intended to provide unbiased, evidence-based information so that patients, clinicians and others can make the best possible treatment decisions.
Although non-insulin oral medications are used as a first-line treatment for patients with type 2 diabetes, insulin is frequently required at some stage during the course of the disease. Under such circumstances, some patients are controlled with long-acting insulin alone while others need a combination of long-acting and rapid-acting insulin to control blood sugar levels after meals, especially meals with high sugar content.
AHRQ Director Carolyn M. Clancy, M.D. said,
“While it is clear that pre-mixed insulin analogues offer certain advantages to patients with diabetes, what is good for one patient may not be good for another. This report offers an important reminder that patients with diabetes should review their treatment plans carefully with their physician.”
Source: Market Watch
Filed under Blood Sugar Testing, Insulin, NIDDM, Obesity | Tags: conventional pre-mixed human insulin, Johns Hopkins University, non-insulin oral medications, Pre-mixed insulin analogues, rapid-acting insulin | Comment Below